This inventor holds 1 USPTO granted patent. Top assignee: Kymab Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Li-Tzu Chen
Introduction
Li-Tzu Chen is a prominent inventor based in Xinyi District, Taipei, Taiwan. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. Her innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Li-Tzu Chen holds a patent for PCSK9 antagonists. This invention relates to Proprotein Convertase Subtilisin Kexin type 9 (PCSK9) antagonists, including antibodies and fragments. The patent also covers methods, uses, and combinations of these antagonists, which have the potential to revolutionize treatments for cholesterol-related conditions.
Career Highlights
Li-Tzu Chen is currently associated with Kymab Limited, a company known for its cutting-edge research in immunology and biotechnology. Her work at Kymab has positioned her as a key player in the development of novel therapeutic solutions.
Collaborations
Throughout her career, Li-Tzu Chen has collaborated with notable professionals in her field, including Allan Bradley and Qi Liang. These collaborations have enhanced her research and contributed to the advancement of her inventions.
Conclusion
Li-Tzu Chen's innovative contributions to biotechnology, particularly through her patent on PCSK9 antagonists, highlight her role as a leading inventor in her field. Her work continues to inspire advancements in medical treatments and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile